Home Newsfeeds HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

HC Wainwright & Co. analyst Ed Arce maintains Terns Pharma (NASDAQ:TERN) with a Neutral and raises the price target from $6 to $7.

byBenzinga Newsdesk

December 29, 2022

1 minute read

HC Wainwright & Co. analyst Ed Arce maintains Terns Pharma (NASDAQ:TERN) with a Neutral and raises the price target from $6 to $7.

Morgan Stanley Maintains Equal-Weight on Docebo, Lowers Price Target to $36

By Benzinga Newsdesk

November 11, 9:35 AM

Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Equal-Weight and lowers the price target from $40 to $36.

DCBO

News
Tech

Tesla Users Continue To Request Removal Of Steering Wheel ‘Nag’ Despite Musk’s Promises For A Fix

By Anan Ashraf

November 13, 5:59 AM

Tesla users are still struggling with its 'steering wheel nag' while under full self-driving mode despite Musk's multiple proposed timelines for a fix.

TSLA

Analysts Divided On Zoom’s Future: Solid Performance Marred By Growth Concerns

By Priya Nigam

May 23, 12:21 PM

Shares of Zoom Video Communications Inc (NASDAQ: ZM) tanked in early trading on Tuesday, despite the company reporting upbeat revenues and earnings for its first quarter.

MarketAxess Holdings Q4 EPS $1.58 Beats $1.56 Estimate, Sales $177.90M Beat $176.92M Estimate

By Bill Haddad

January 25, 7:36 AM

MarketAxess Holdings (NASDAQ:MKTX) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.56 by 1.28 percent. This is a 15.33 percent increase over earnings of $1.37 per share from

MKTX

HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

Related Posts

Morgan Stanley Maintains Equal-Weight on Docebo, Lowers Price Target to $36

Tesla Users Continue To Request Removal Of Steering Wheel ‘Nag’ Despite Musk’s Promises For A Fix

Analysts Divided On Zoom’s Future: Solid Performance Marred By Growth Concerns

MarketAxess Holdings Q4 EPS $1.58 Beats $1.56 Estimate, Sales $177.90M Beat $176.92M Estimate